Celecoxib 200 mg/day has a beneficial anti-inflammatory effect in patients with AS

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1278, 2001-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjunct methotrexate has anti-inflammatory effect in CHF

By  

Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A-Viral has advised that a trial of AV 1101 has been temporarily suspended as it `seems likely' that AV 1101 200 mg/day, given in combination

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A fluconazole dosage of 200 mg/day is sufficient to prevent yeast colonisation

By  

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Enzastaurin 525 mg/day is the recommended dosage for patients with cancer, and it is well tolerated at dosages of up to 700 mg/day

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib

By Tamilvanan S.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 761-771

Informa Healthcare

Access to resources Recommend Favorite